Enlibio，Your biological research partner ！
Enlibio Biotech Co.,Ltd,Wuhan,China 2008-2022
R&D 14th year
| Evolution of synchronous female bilateral breast cancers and response to treatment | [ Biological abstract ] | 2023-03-15 |
| Non-canonical functions of SNAIL drive context-specific cancer progression | [ Biological abstract ] | 2023-03-15 |
| SOX11 regulates SWI/SNF complex components as member of the adrenergic neuroblastoma core regulatory | [ Biological abstract ] | 2023-03-15 |
| Single-cell transcriptome profiling of the stepwise progression of head and neck cancer | [ Biological abstract ] | 2023-03-06 |
| PHGDH arginine methylation by PRMT1 promotes serine synthesis and represents a therapeutic vulnerabi | [ Biological abstract ] | 2023-03-06 |
| Analysis of acquired resistance mechanisms to osimertinib in patients with EGFR-mutated advanced non | [ Biological abstract ] | 2023-03-03 |
| Structural mechanism for inhibition of PP2A-B56α and oncogenicity by CIP2A | [ Biological abstract ] | 2023-03-03 |
| Genomic and immune landscape Of metastatic pheochromocytoma and paraganglioma | [ Biological abstract ] | 2023-03-03 |
|
|
